Galderma Investigational site

New York, New York 10155

0 studies enrolling now · 7 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Keratosis, Actinic, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study — Stopped early
• CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris — Completed
• Dose-ranging Study of Nemolizumab in Atopic Dermatitis — Completed
• Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris — Completed